Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection) 7/9/20 Eagle Pharmaceuticals to Present at June Investor Conferences 5/26/20 Eagle Pharmaceuticals Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders 5/22/20 Eagle Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference 5/12/20 Eagle Pharmaceuticals Reports First Quarter 2020 Results 5/11/20 Eagle Pharmaceuticals Advances Novel and Proprietary Formulation of Fulvestrant Product Candidate EA-114; Company to Request Additional Meeting with U.S. Food and Drug Administration (“FDA”) 5/4/20 Eagle Pharmaceuticals to Discuss First Quarter 2020 Financial Results on May 11, 2020 4/29/20 Court Issues Favorable Patent Litigation Decision for Eagle Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. for BENDEKA (bendamustine hydrochloride injection) 4/28/20 Eagle Pharmaceuticals Announces Laboratory Test Results Demonstrating In Vitro Antiviral Activity of RYANODEX® (dantrolene sodium) Against Coronavirus SARS-CoV-2 4/16/20 Eagle Pharmaceuticals’ Japanese Licensing Partner SymBio Announces Completion of Clinical Trial Enrollment for TREAKISYM® Rapid Infusion Liquid Bendamustine Formulation 3/30/20 Pagination First page Previous page Page 1 Current page 2 Page 3 Next page Last page
